| (Values in U.S. Thousands) | Mar, 2008 | Mar, 2007 | Mar, 2006 | Mar, 2005 | Mar, 2004 |
| Sales | 0 | 18,980 | 22,350 | 24,290 | 21,540 |
| Sales Growth | -100.00% | -15.08% | -7.99% | +12.77% | +13.49% |
| Net Income | -8,600 | -3,410 | -670 | 1,810 | 1,000 |
| Net Income Growth | -152.20% | -408.96% | -137.02% | +81.00% | +129.33% |
Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Chad Therapeutics develops, produces and markets respiratory care devices designed to improve the efficiency of oxygen delivery systems for both home and hospital treatment of patients who require supplemental oxygen. These are primarily patients suffering from chronic obstructive pulmonary diseases.
Fiscal Year End Date: 03/31